Annual Financials for ICU Medical Inc.
Assets
Fiscal year is January-December. All values USD millions. |
2017 | 2018 | 2019 | 2020 | 2021 |
5-year trend |
Cash & Short Term Investments |
300.13M | 382.11M | 292.64M | 410.78M | 567.25M | |
Cash Only |
290.07M | 344.78M | 268.67M | 396.1M | 552.83M | |
Short-Term Investments |
10.06M | 37.33M | 23.97M | 14.69M | 14.42M | |
Cash & Short Term Investments Growth |
- | 27.31% | -23.42% | 40.37% | 38.09% | |
Cash & ST Investments / Total Assets |
20.05% | 24.10% | 17.29% | 23.29% | 30.16% | |
Total Accounts Receivable |
211.5M | 196.44M | 206.64M | 127.77M | 110.05M | |
Accounts Receivables, Net |
211.5M | 196.44M | 202.22M | 124.09M | 105.89M | |
Accounts Receivables, Gross |
214.81M | 202.2M | 215.71M | 145.58M | 112.93M | |
Bad Debt/Doubtful Accounts |
(3.31M) | (5.77M) | (13.49M) | (21.49M) | (7.04M) | |
Other Receivables |
- | - | 4.42M | 3.68M | - | |
Accounts Receivable Growth |
- | -7.12% | 5.20% | -38.17% | -13.87% | |
Accounts Receivable Turnover |
6.11 | 7.13 | 6.13 | 9.95 | 11.96 | |
Inventories |
288.66M | 311.16M | 337.64M | 314.93M | 290.24M | |
Finished Goods |
163.96M | 154.15M | 178.42M | 155.38M | 118.22M | |
Work in Progress |
42.3M | 52.91M | 39.52M | 33.05M | 36.49M | |
Raw Materials |
82.4M | 104.1M | 119.71M | 126.5M | 135.53M | |
Progress Payments & Other |
- | - | - | - | - | |
Other Current Assets |
64.37M | 35.38M | 41.95M | 60.89M | 49.53M | |
Miscellaneous Current Assets |
38.89M | 16.29M | 20.78M | 25.24M | 23.64M | |
Total Current Assets |
864.66M | 925.09M | 878.87M | 914.38M | 1.02B | |
|
2017 | 2018 | 2019 | 2020 | 2021 |
5-year trend |
Net Property, Plant & Equipment |
398.68M | 432.64M | 490.55M | 513.2M | 508.21M | |
Property, Plant & Equipment - Gross |
608.82M | 694.86M | 810.71M | 889.67M | 944.95M | |
Buildings |
206.85M | 212.28M | 230.45M | 241.2M | 243.38M | |
Land & Improvements |
- | - | - | - | - | |
Computer Software and Equipment |
44.41M | 80.42M | 83.22M | 98.31M | 102.98M | |
Other Property, Plant & Equipment |
79.43M | 127.87M | 142.09M | 158.53M | 165.52M | |
Accumulated Depreciation |
210.14M | 262.22M | 320.16M | 376.47M | 436.74M | |
Total Investments and Advances |
14.58M | 2.57M | - | 12.97M | 7.86M | |
Other Long-Term Investments |
14.58M | 2.57M | - | 12.97M | 4.62M | |
Long-Term Note Receivable |
- | - | - | - | 25.94M | |
Intangible Assets |
156.11M | 144.62M | 242.65M | 230.23M | 231.75M | |
Net Goodwill |
12.36M | 11.2M | 31.25M | 33M | 43.44M | |
Net Other Intangibles |
143.75M | 133.42M | 211.41M | 197.23M | - | |
Other Assets |
38.14M | 41.83M | 52.32M | 61.88M | 47.31M | |
Tangible Other Assets |
38.14M | 39.87M | 48.98M | 55.48M | 31.74M | |
Total Assets |
1.5B | 1.59B | 1.69B | 1.76B | 1.88B | |
Assets - Total - Growth |
- | 5.91% | 6.75% | 4.21% | 6.64% | |
Liabilities & Shareholders' Equity
|
2017 | 2018 | 2019 | 2020 | 2021 |
5-year trend |
ST Debt & Current Portion LT Debt |
- | - | 7.36M | 9.29M | 9.65M | |
Short Term Debt |
- | - | 7.36M | 8.74M | - | |
Current Portion of Long Term Debt |
- | - | - | 554,000 | 643,000 | |
Accounts Payable |
78.23M | 120.47M | 128.63M | 71.86M | 81.13M | |
Accounts Payable Growth |
- | 54.00% | 6.77% | -44.13% | 12.89% | |
Income Tax Payable |
- | 2.94M | 4.68M | 2.45M | 3.43M | |
Other Current Liabilities |
132.06M | 125.88M | 107.8M | 111.88M | 106.56M | |
Dividends Payable |
- | - | - | - | - | |
Accrued Payroll |
61.43M | 63.45M | 36.34M | 52.81M | 60.41M | |
Miscellaneous Current Liabilities |
70.64M | 62.43M | 71.46M | 59.07M | 46.15M | |
Total Current Liabilities |
210.29M | 249.29M | 248.47M | 195.49M | 200.78M | |
Long-Term Debt |
- | - | 28.9M | 43.41M | 36.04M | |
Long-Term Debt excl. Capitalized Leases |
- | - | - | - | - | |
Non-Convertible Debt |
- | - | - | - | - | |
Convertible Debt |
- | - | - | - | - | |
Capitalized Lease Obligations |
- | - | - | 2.39M | 2.07M | |
Provision for Risks & Charges |
27M | - | - | - | - | |
Deferred Taxes |
(23.29M) | (37.93M) | (25.91M) | (29.37M) | (41.11M) | |
Deferred Taxes - Credit |
1.49M | 721,000 | 2.09M | 1.66M | 1.49M | |
Deferred Taxes - Debit |
24.78M | 38.65M | 28M | 31.03M | 42.6M | |
Other Liabilities |
59.92M | 71.73M | 35.68M | 20.87M | 26.4M | |
Other Liabilities (excl. Deferred Income) |
52.82M | 71.26M | 35.59M | 19.67M | 26.2M | |
Deferred Income |
7.1M | 468,000 | 94,000 | 1.2M | 202,000 | |
Total Liabilities |
298.7M | 321.74M | 315.14M | 261.43M | 264.71M | |
Non-Equity Reserves |
- | - | - | - | - | |
Total Liabilities / Total Assets |
19.95% | 20.29% | 18.62% | 14.82% | 14.07% | |
Preferred Stock (Carrying Value) |
- | - | - | - | - | |
Redeemable Preferred Stock |
- | - | - | - | - | |
Non-Redeemable Preferred Stock |
- | - | - | - | - | |
Common Equity (Total) |
1.2B | 1.26B | 1.38B | 1.5B | 1.62B | |
Common Stock Par/Carry Value |
2.02M | 2.05M | 2.07M | 2.11M | 2.13M | |
Retained Earnings |
585.62M | 620.75M | 721.78M | 808.65M | 911.79M | |
ESOP Debt Guarantee |
- | - | - | - | - | |
Cumulative Translation Adjustment/Unrealized For. Exch. Gain |
(14.58M) | (17.68M) | (17.31M) | (4.38M) | (19.05M) | |
Unrealized Gain/Loss Marketable Securities |
- | - | - | - | - | |
Revaluation Reserves |
- | - | - | - | - | |
Treasury Stock |
- | (95,000) | (157,000) | (39,000) | (27,000) | |
Common Equity / Total Assets |
80.05% | 79.71% | 81.38% | 85.18% | 85.93% | |
Total Shareholders' Equity |
1.2B | 1.26B | 1.38B | 1.5B | 1.62B | |
Total Shareholders' Equity / Total Assets |
80.05% | 79.71% | 81.38% | 85.18% | 85.93% | |
Accumulated Minority Interest |
- | - | - | - | - | |
Total Equity |
1.2B | 1.26B | 1.38B | 1.5B | 1.62B | |
Liabilities & Shareholders' Equity |
1.5B | 1.59B | 1.69B | 1.76B | 1.88B | |